Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
15.74
+0.24 (1.55%)
At close: Feb 6, 2026
Astellas Pharma Employees
Astellas Pharma had 13,643 employees as of March 31, 2025. The number of employees decreased by 1,111 or -7.53% compared to the previous year.
Employees
13,643
Change (1Y)
-1,111
Growth (1Y)
-7.53%
Revenue / Employee
$963,327
Profits / Employee
$150,959
Market Cap
27.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 13,643 | -1,111 | -7.53% |
| Mar 31, 2024 | 14,754 | 270 | 1.86% |
| Mar 31, 2023 | 14,484 | -38 | -0.26% |
| Mar 31, 2022 | 14,522 | -933 | -6.04% |
| Mar 31, 2021 | 15,455 | -428 | -2.69% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Astellas Pharma News
- 4 days ago - Astellas Pharma ADR GAAP EPS of ¥185.20, revenue of ¥1601.32B; updates full-year forecast - Seeking Alpha
- 26 days ago - Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 4 weeks ago - Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 7 weeks ago - Astellas Reports Positive Phase 3 EV-304 Results For PADCEV Combo In Muscle-Invasive Bladder Cancer - Nasdaq
- 7 weeks ago - Why Is Monte Rosa Stock Trading Higher Today? - Benzinga
- 2 months ago - Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines - GlobeNewsWire
- 2 months ago - Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium - PRNewsWire